PATENT CLAIM ANALYSIS

Application Number: 16222823
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["606", "041000"]

Abstract:
Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are method of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.

Claim (Index 5):
The method of  claim 1 , wherein advancing the ablation element from the azygous vein into a T9, T10, or T11 intercostal vein comprises advancing the ablation element from the azygous into a T11 intercostal.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 98.0
- Lexical Diversity: 1.87302
- Patent Class: 606.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15017351', '15140254', '13933023', '15677978', '13869765']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7737537449094469
- 35 USC 102 Novelty (BERT): 0.4939663538421952
- Combined Prediction Score: 0.7457750058027218
- Mean Citation Score: 265.42406800000003
- Max Citation Score: 387.08572
- Similarity Product: 232.45999000255344

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test